Hainan Poly Pharm Co Ltd
SZSE:300630
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hainan Poly Pharm Co Ltd
SZSE:300630
|
CN |
|
Shanghai Fortune Techgroup Co Ltd
SZSE:300493
|
CN |
|
S
|
Shaanxi Energy Investment Co Ltd
SZSE:001286
|
CN |
|
Zhejiang XinNong Chemical Co Ltd
SZSE:002942
|
CN |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
V
|
Vaisala Oyj
OMXH:VAIAS
|
FI |
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
SSE:601869
|
CN |
|
Macrotech Developers Ltd
BSE:543287
|
IN |
|
BRB-Banco de Brasilia SA
BOVESPA:BSLI4
|
BR |
|
Eoptolink Technology Inc Ltd
SZSE:300502
|
CN |
|
G
|
GuangZhou Wahlap Technology Co Ltd
SZSE:301011
|
CN |
|
G
|
GCH Technology Co Ltd
SSE:688625
|
CN |
|
Jl Mag Rare-Earth Co Ltd
SZSE:300748
|
CN |
|
Casa Holdings Ltd
SGX:C04
|
SG |
|
Ventia Services Group Ltd
ASX:VNT
|
AU |
|
Mahindra Lifespace Developers Ltd
NSE:MAHLIFE
|
IN |
|
General Insurance Corporation of India
NSE:GICRE
|
IN |
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
IN |
Bankruptcy Probability
Hainan Poly Pharm Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hainan Poly Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
H
|
Hainan Poly Pharm Co Ltd
SZSE:300630
|
68.4m CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hainan Poly Pharm Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hainan Poly Pharm Co Ltd has total debt of 2.2B CNY. This includes both short-term (320.6m CNY) and long-term (1.9B CNY) debt.
You can find a full breakdown on its Balance Sheet.
